Literature DB >> 24535131

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

U Gergis1, S Mayer1, B Gordon1, T Mark1, R Pearse1, T Shore1, K Van Besien1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24535131     DOI： 10.1038/bmt.2014.11

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.

Authors:  Ryan J Hansen; Joseph P Balthasar
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249

2.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Authors:  Corey Cutler; Haesook T Kim; Lixian Sun; Doreen Sese; Brett Glotzbecker; Philippe Armand; John Koreth; Vincent Ho; Edwin Alyea; Karen Ballen; Jerome Ritz; Robert J Soiffer; Edgar Milford; Joseph H Antin
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

3.  Durability of antibody removal following proteasome inhibitor-based therapy.

Authors:  Matthew J Everly; Paul I Terasaki; Hargovind L Trivedi
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

4.  Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.

Authors:  Marie Detrait; Valérie Dubois; Mohamad Sobh; Stéphane Morisset; Nathalie Tedone; Hélène Labussière; Lilia Gillis; Fiorenza Barraco; Giovanna Cannas; Sophie Ducastelle; Jihane Fatoum; Xavier Thomas; Youcef Chelgoum; Franck-Emmanuel Nicolini; Mauricette Michallet
Journal:  Exp Hematol       Date:  2012-06-12       Impact factor: 3.084

5.  Anti-HLA antibodies in double umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Harriet Noreen; Todd E DeFor; David Maurer; Jeffrey S Miller; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-03       Impact factor: 5.742

6.  Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Peter F Thall; Xuemei Wang; Sa A Wang; Ying Hu; Pedro Cano; Fleur Aung; Gabriela Rondon; Jeffrey J Molldrem; Martin Korbling; Elizabeth J Shpall; Marcos de Lima; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

7.  Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Authors:  Carlos A Vieira; Avinash Agarwal; Benita K Book; Richard A Sidner; Christopher M Bearden; Howard M Gebel; Anthony L Roggero; Naomi S Fineberg; Timothy Taber; Michael A Kraus; Mark D Pescovitz
Journal:  Transplantation       Date:  2004-02-27       Impact factor: 4.939

8.  Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

Authors:  Douglas E Gladstone; Andrea A Zachary; Ephraim J Fuchs; Leo Luznik; Yvette L Kasamon; Karen E King; Robert A Brodsky; Richard J Jones; Mary S Leffell
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-22       Impact factor: 5.742

9.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

Authors:  C Anasetti; D Amos; P G Beatty; F R Appelbaum; W Bensinger; C D Buckner; R Clift; K Doney; P J Martin; E Mickelson
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245
  9 in total
  6 in total

1.  Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

Authors:  Koen van Besien; Parameswaran Hari; Mei-Jie Zhang; Hong-Tao Liu; Wendy Stock; Lucy Godley; Olatoyosi Odenike; Richard Larson; Michael Bishop; Amittha Wickrema; Usama Gergis; Sebastian Mayer; Tsiporah Shore; Stephanie Tsai; Joanna Rhodes; Melissa M Cushing; Sandra Korman; Andrew Artz
Journal:  Haematologica       Date:  2016-02-11       Impact factor: 9.941

2.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Authors:  Stephanie B Tsai; Hongtao Liu; Tsiporah Shore; Yun Fan; Michael Bishop; Melissa M Cushing; Usama Gergis; Lucy Godley; Justin Kline; Richard A Larson; Guadalupe Martinez; Sebastian Mayer; Olatoyosi Odenike; Wendy Stock; Amittha Wickrema; Koen van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-19       Impact factor: 5.742

3.  Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption.

Authors:  C M Wilk; J C Fischer; G Schieren; J M Rox; R Haas; L C Rump; G Kobbe; T Schroeder
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

Review 4.  HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities.

Authors:  Douglas E Gladstone; Maria P Bettinotti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Cord blood chimerism and relapse after haplo-cord transplantation.

Authors:  Koen van Besien; Nebu Koshy; Usama Gergis; Sebastian Mayer; Melissa Cushing; Hannah Rennert; Ronit Reich-Slotky; Tomer Mark; Roger Pearse; Adriana Rossi; Adrienne Phillips; Liljana Vasovic; Rosanna Ferrante; Yen-Michael Hsu; Tsiporah Shore
Journal:  Leuk Lymphoma       Date:  2016-06-23

6.  Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.

Authors:  Rongli Zhang; Yi He; Donglin Yang; Erlie Jiang; Qiaoling Ma; Aiming Pang; Weihua Zhai; Jialin Wei; Sizhou Feng; Mingzhe Han
Journal:  J Clin Lab Anal       Date:  2020-02-28       Impact factor: 2.352
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.